查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018800

兽用人工授精市场：依动物种类、产品类型、最终用户及技术划分－2026-2032年全球市场预测

Veterinary Artificial Insemination Market by Animal Type, Product Type, End User, Technology Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，兽用人工授精市场价值将达到 55.5 亿美元，到 2026 年将成长至 59.6 亿美元，到 2032 年将达到 90.8 亿美元，复合年增长率为 7.28%。

主要市场统计数据
基准年 2025 55.5亿美元
预计年份：2026年 59.6亿美元
预测年份 2032 90.8亿美元
复合年增长率 (%) 7.28%

简明策略介绍，概述了正在重塑兽医人工授精实践的技术进步、营运重点和商业性需求。

兽医人工授精领域正步入一个关键阶段，其特点是技术快速发展、畜牧业经济格局变化以及动物健康优先事项的转变。本文概述了现代兽医人工授精技术在生殖生物技术发展大背景下的应用，阐述了设备、精液处理和技术应用方面的逐步改进如何共同提升了成功率和运营效率。随着相关人员日益重视遗传结果、生物安全和成本效益，科学创新和主导需求的共同作用正在重塑这一领域。

展望兽医人工授精领域，技术、营运和数据驱动的变革正在重新定义能力发展和价值创造。

兽医人工授精领域正经历着一场变革，其驱动力包括技术的成熟、终端用户需求的不断变化以及对遗传优化的日益重视。精液处理和储存方法的进步提高了解冻后的存活率，而人工授精设备的自动化和人体工学的改进则降低了操作人员的差异性，并扩大了熟练技术人员的队伍。同时，从传统方法到更深层的子宫颈内授精技术以及性别分选精液的应用，技术的改进使得繁殖结果更加精准，进而影响着畜群的遗传特性和生产力。

详细检验2025 年关税措施如何重塑整个人工智慧价值链的筹资策略、供应链韧性和采购行为。

关税趋势和不断变化的贸易政策正在给兽医人工授精所需的精液、专用设备和耗材的采购和跨境分销带来显着的摩擦。 2025年，某些投入品关税的提高和物流成本的上升将影响筹资策略，迫使各机构评估替代供应商、实现供应链的地域多角化，并在可能的情况下将关键职能内部化。这些调整正在对营运产生切实的影响。具体而言，低温储罐和解冻设备的前置作业时间延长，以及进口冷冻和冷藏精液的相对成本计算方式发生变化，导致库存管理和合约谈判更加谨慎。

从全面的、细分主导的观点，揭示物种需求、产品等级趋势、最终用户需求以及技术采用。

细分市场洞察揭示了不同动物种类、产品架构、终端用户画像和技术采纳路径所存在的细微机会领域和营运挑战。按动物种类分析，牛的育种项目仍然是高通量遗传改良倡议的主要关注点，而马的应用则优先考虑以性能为导向的育种和兽医主导的繁殖管理。绵羊和山羊的育种计画着重于畜群层面的效率和疾病管理，而猪的育种中心则越来越多地将人工授精（AI）作为一种标准的生物安全育种方法。这些差异会影响产品选择、技术偏好和服务频率，因此供应商需要根据特定物种的繁殖週期和处理容量要求来调整其价值提案。

针对特定区域的分析，解释了不同的法规环境、生产系统和物流现实如何影响人工智慧的采用和商业策略。

区域趋势对整个兽用人工授精领域的策略、产品开发重点和推广曲线有显着影响。在美洲，从大规模商业性牛到小规模混合农场，多样化的生产系统推动了对各种解决方案的需求。强大的本土製造业为具有竞争力的设备和本地化的服务网络提供了保障。在欧洲、中东和非洲，法律规范、动物健康标准和遗传可追溯性要求影响先进育种技术的应用。同时，区域贸易走廊和物流基础设施为精液材料的跨境分销带来了机会和挑战。在亚太地区，畜牧系统的快速现代化、旨在提高生产力的强有力的政府计划以及积极的私营部门投资正在加速耗材和精密设备的普及。然而，分散的市场结构往往需要针对特定市场制定通路策略。

对推动兽医人工授精生态系统绩效和整合的竞争因素、伙伴关係模式和基于能力的差异化进行策略性评估。

竞争格局的特点是专业设备製造商、精液供应商和服务型企业相互交织，共同致力于提升兽医人工授精领域的服务能力和可及性。领先的设备製造商透过投资耐用材料、符合人体工学的设计以及实现可追溯性和操作指导的数位化整合来脱颖而出。另一方面，精液供应商则在遗传品质保证、严格的加工流程和低温运输完整性方面竞争。服务供应商和人工授精中心则透过扩展技术人员培训计画、完善的繁殖结果记录以及提供根据农场和诊所工作流程量身定制的综合服务合约来提升自身竞争力。

为高阶主管制定了一系列可操作的优先事项，以加强供应链韧性、加速技术采用，并在整个业务中建立以服务主导的差异化优势。

产业领导者应优先采取一系列切实可行的措施，以增强韧性、加速高精度技术的应用并扩大商业性覆盖范围。首先，透过寻找关键耗材的替代供应商，并探索本地组装和库存策略，降低关税和物流风险，从而投资供应链冗余。其次，将产品创新与全面的培训计画相结合，以减少操作人员的差异，并降低采用子宫颈深部注射和性别分选精液技术的门槛。第三，加强仪器与畜牧管理系统之间的数位化集成，将操作数据转化为可复製的最佳实践，并向最终用户展示投资回报。

我们采用透明的混合研究途径，结合一手访谈、技术审计和证据整合，确保策略结论是基于实地实际情况。

本分析所依据的研究采用混合方法，结合了对关键相关人员的访谈、技术审核以及对同行评审的生殖生物学文献的系统性整合，以得出可靠且可操作的结论。主要工作包括对设备工程师、育种兽医、人工授精中心经理和农场营运经理进行结构化访谈，以确定实际限制因素和推广应用的驱动因素。为了补充这些定性研究结果，研究人员还对设备规格、耗材性能数据和操作规程进行了技术审核，以评估其可靠性以及是否符合当前的最佳实践。

简洁扼要的结论强调了技术进步、供应链韧性和服务整合如何相互作用，从而为不断改进人工智慧实践奠定基础。

这项结论整合了技术成熟度、供应链韧性和客製化服务模式这三大核心主题，并表明这些要素的融合正在塑造一个更注重结果的兽医人工智慧环境。随着技术的成熟和数位化整合的普及，相关人员将获得无可比拟的价值。 2025年关税相关的衝击凸显了灵活采购和近岸外包方案的必要性。同时，区域差异也强调了製定在地化打入市场策略和支援策略的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：兽用人工授精市场：依动物类型划分

  • 牛
  • 马
  • 绵羊/山羊
  • 猪

第九章 兽用人工授精市场：依产品类型划分

  • 消耗品
    • 冲淡
    • 移液器
    • 稻草
  • 装置
    • AI枪
    • 低温储罐
    • 解冻装置
  • 精液
    • 冷藏
    • 生精液
    • 冰冻

第十章 兽用人工授精市场：依最终用户划分

  • 人工授精中心
  • 农场
  • 动物医院

第十一章 兽用人工授精市场：依技术类型划分

  • 传统人工智慧
  • 深部子宫颈内法
  • 利用性别分选精子进行人工授精

第十二章 兽用人工授精市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 兽用人工授精市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 兽用人工授精市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国兽用人工授精市场

第十六章：中国兽用人工授精市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ABS Global, Inc.
  • Alta Genetics
  • Bovine Elite LLC
  • Boviteq Inc.
  • CRV BV
  • Genus ABS
  • Genus plc
  • IMV Technologies SAS
  • Inguran GmbH
  • Merck & Co., Inc.
  • Minitube International GmbH
  • Neogen Corporation
  • Select Sires Inc.
  • Semex Alliance Inc.
  • STgenetics
  • Topigs Norsvin NV
  • TransOva Genetics
  • Valley Vet Supply
  • Vytelle, Inc.
  • Zoetis Inc.
Product Code: MRR-ED54C46E84F6

The Veterinary Artificial Insemination Market was valued at USD 5.55 billion in 2025 and is projected to grow to USD 5.96 billion in 2026, with a CAGR of 7.28%, reaching USD 9.08 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.55 billion
Estimated Year [2026] USD 5.96 billion
Forecast Year [2032] USD 9.08 billion
CAGR (%) 7.28%

A concise strategic introduction framing technological evolution, operational priorities, and commercial imperatives reshaping veterinary artificial insemination practice

The veterinary artificial insemination field has entered a pivotal phase characterized by rapid technological refinement, shifting farm economics, and evolving animal health priorities. This introduction situates contemporary practice within the broader trajectory of reproductive biotechnology, outlining how incremental improvements in instrumentation, seminal handling, and technique adoption have collectively elevated success rates and operational efficiency. As stakeholders increasingly prioritize genetic outcomes, biosecurity, and cost-effectiveness, the discipline is being reshaped by a confluence of scientific innovation and market-driven imperatives.

Moreover, demographic and supply-chain dynamics are prompting providers and end users to re-evaluate service delivery models. Veterinary clinics and AI centers alike are integrating digital tools for recordkeeping, heat detection, and herd-management analytics, while farms reassess in-house capabilities versus outsourced services. In this context, the introduction foregrounds the strategic questions that will guide investment and operational choices in the near term: how to balance capital intensity in equipment against consumable reliability, how to deploy emerging technologies to reduce variability in outcomes, and how to align technique selection with species-specific reproductive physiology and producer objectives. The following sections expand on transformative shifts, tariff impacts, segmentation insights, and regional patterns that are central to informed decision-making.

A forward-looking synthesis of technological, operational, and data-driven shifts that are redefining capability deployment and value creation in veterinary AI

The landscape of veterinary artificial insemination is experiencing transformative shifts driven by technological maturation, changing end-user expectations, and a heightened focus on genetic optimization. Advances in semen processing and preservation methods are improving post-thaw viability, while automation and improved ergonomics in AI equipment are lowering operator variability and expanding the pool of competent technicians. Concurrently, refinements in technique-ranging from conventional approaches to deeper intracervical methods and sexed semen applications-are enabling more precise reproductive outcomes, which in turn influence herd genetics and production economics.

In addition, the convergence of data-driven herd management and reproductive services is altering service delivery frameworks. AI centers and veterinary clinics are increasingly integrating electronic records, reproductive performance analytics, and traceability functions to demonstrate value to farmers. These shifts are accompanied by a renewed emphasis on biosecurity and traceability, elevating standards for seminal materials handling and cryogenic storage. Finally, market dynamics are fostering specialized supply chains for consumables and instruments, prompting manufacturers to innovate on durability, ease of use, and compatibility with diverse seminal formats. Taken together, these elements are catalyzing a more sophisticated, outcomes-oriented ecosystem that rewards precision, repeatability, and demonstrable animal welfare benefits.

An in-depth examination of how 2025 tariff measures have reshaped sourcing strategies, supply chain resiliency, and procurement behavior across the AI value chain

Tariff dynamics and trade policy developments have introduced material friction into the procurement and cross-border distribution of seminal materials, specialized equipment, and consumables used in veterinary artificial insemination. In 2025, heightened duties on select inputs and logistics cost increases have influenced sourcing strategies, compelling organizations to evaluate alternative suppliers, regionalize supply chains, and insource critical capabilities where feasible. These adjustments have tangible operational consequences: lead times for cryogenic tanks and thawing devices have lengthened, and the relative cost calculus of importing frozen versus chilled semen has shifted, prompting more cautious inventory management and contract negotiation practices.

As a result, buyers are demonstrating increased interest in local certification pathways and in establishing redundant sourcing arrangements to mitigate tariff-induced volatility. Technology vendors and distributors are responding by revising pricing frameworks, offering extended-service models, and exploring localized manufacturing or assembly to preserve competitiveness. Importantly, end users such as farms and AI centers are adjusting scheduling and reproductive planning to accommodate variability in consumable availability. While tariffs have not halted innovation, they have accelerated strategic realignment across the value chain, making resilience, supplier diversification, and nearshoring critical priorities for organizations that rely on timely access to advanced seminal materials and precision equipment.

A comprehensive segmentation-driven perspective revealing species-specific demands, product tier dynamics, end-user requirements, and technology-specific adoption profiles

Segmentation insights reveal nuanced opportunity spaces and operational imperatives that vary by animal type, product architecture, end-user profile, and technology pathways. When analyzing by animal type, bovine programs remain a dominant focus for high-throughput genetic improvement initiatives, while equine applications prioritize performance breeding and veterinary-led reproductive management; ovine and caprine programs emphasize flock-level efficiency and disease control, and swine breeding centers increasingly integrate AI as a standard biosecure reproduction method. These distinctions influence product selection, technique preference, and service frequency, requiring suppliers to tailor value propositions by species-specific reproductive cycles and throughput requirements.

From a product type perspective, consumables such as extenders, pipettes, and straws are evaluated for consistency, sterility, and cold-chain robustness, while equipment categories including AI guns, cryogenic storage tanks, and thawing devices are judged on reliability, ergonomic design, and maintenance needs. Seminal materials present their own segmentation: chilled options offer logistical flexibility for short-distance transfers, fresh semen suits immediate on-farm insemination, and frozen formats enable long-term storage and international genetic exchange. Across end users, AI centers demand high-throughput, traceability-focused solutions; farms balance cost and in-house capability; and veterinary clinics emphasize precision and animal welfare. Lastly, technology type segmentation highlights how conventional AI, deep intracervical techniques, and sexed semen applications each require specific training, equipment standards, and handling protocols, underscoring the importance of end-to-end support for successful adoption.

A regionally attuned analysis explaining how diverse regulatory environments, production systems, and logistics realities shape AI adoption and commercial strategies

Regional dynamics exert significant influence on strategy, product development priorities, and adoption curves across the veterinary artificial insemination landscape. In the Americas, diverse production systems-from large-scale commercial bovine operations to smallholder mixed farms-drive demand for a wide range of solutions, and robust domestic manufacturing supports competitive equipment availability and localized service networks. In Europe, Middle East & Africa, regulatory frameworks, animal health standards, and genetic-traceability requirements shape the adoption of advanced reproductive technologies, while regional trade corridors and logistics infrastructure create both opportunities and constraints for cross-border distribution of seminal materials. In Asia-Pacific, rapid modernization of livestock systems, strong governmental programs aimed at productivity enhancement, and active private-sector investment have accelerated uptake of both consumables and precision equipment, although fragmented market structures mean that tailored channel strategies are often necessary.

Consequently, companies operating across regions must adapt go-to-market approaches, compliance strategies, and service models to local conditions and stakeholder expectations. For instance, solutions that emphasize ease of use and low maintenance resonate strongly in remote production zones, while centralized AI centers in denser agricultural regions prioritize throughput, traceability, and integration with herd-management platforms. Understanding these regional nuances is essential for designing distribution partnerships, after-sales support networks, and training programs that align with local competencies and commercial realities.

A strategic appraisal of competitive forces, partnership models, and capability-based differentiation driving performance and consolidation in the veterinary AI ecosystem

The competitive landscape is characterized by a mix of specialized equipment manufacturers, seminal material suppliers, and service-oriented providers that collectively advance capability and accessibility within veterinary artificial insemination. Leading equipment players differentiate through investments in durable materials, ergonomic designs, and digital integration for traceability and procedural guidance, while seminal suppliers compete on genetic quality assurance, processing rigor, and cold-chain integrity. Service providers and AI centers distinguish themselves by scaling technician training programs, documenting reproductive outcomes, and offering bundled service agreements that align with farm and clinic workflows.

Collaboration between these actor types is increasingly important: manufacturers that partner with leading AI centers gain practical feedback to refine product features, and seminal suppliers that collaborate with veterinary clinics enhance clinical adoption of newer techniques. Additionally, a growing cohort of technology-enabled service platforms is emerging to link genetic suppliers, AI technicians, and end users with scheduling, recordkeeping, and performance analytics. These partnerships and platform plays are accelerating the translation of technical advances into measurable operational improvements and are shaping where investment and consolidation activity is likely to concentrate in the coming years.

A practical set of priority actions for executives to strengthen supply resilience, catalyze technique adoption, and embed service-driven differentiation across operations

Industry leaders should prioritize a set of actionable moves that reinforce resilience, accelerate adoption of higher-precision techniques, and expand commercial reach. First, invest in supply chain redundancy by identifying alternate suppliers for critical consumables and by considering localized assembly or stocking strategies to mitigate tariff and logistics risk. Second, couple product innovation with comprehensive training programs to reduce operator variability and to lower the barrier to adoption for deeper intracervical and sexed semen techniques. Third, strengthen digital integration across equipment and herd-management systems to convert procedural data into reproducible best practices and to demonstrate return on investment to end users.

Furthermore, pursue strategic partnerships that align genetic providers, equipment manufacturers, and service hubs to create bundled offerings tailored to distinct end-user segments, such as high-throughput bovine operations or performance-driven equine breeders. Finally, allocate resources to after-sales service and consumable lifecycle management, as sustained access to sterility-controlled extenders, straws, and pipettes is essential to preserving treatment outcomes and client satisfaction. Implementing these recommendations will enhance operational reliability, support premium service models, and create defensible differentiation in increasingly competitive environments.

A transparent mixed-methods research approach combining primary interviews, technical audits, and evidence synthesis to ground strategic conclusions in operational reality

The research underpinning this analysis integrates a mixed-methods approach combining primary stakeholder interviews, technical audits, and systematic synthesis of peer-reviewed reproductive biology literature to ensure robust, actionable conclusions. Primary engagements included structured interviews with equipment engineers, reproductive veterinarians, AI center managers, and farm operations leads to capture pragmatic constraints and adoption drivers. Complementing these qualitative insights, technical audits of equipment specifications, consumable performance data, and handling protocols were conducted to assess reliability and compatibility with current best practices.

The methodology also involved triangulating primary findings with secondary sources such as regulatory guidance documents, scientific publications on semen preservation and reproductive techniques, and logistics and trade data to understand cross-border implications. Where possible, comparative analyses of technique outcomes and equipment performance were used to identify patterns and inform recommendations. Throughout, data were evaluated for consistency and practical relevance, and uncertainties were explicitly noted to guide interpretation. This structured approach ensures that the analysis is grounded in operational realities and technical evidence while remaining responsive to the strategic questions facing industry decision-makers.

A concise conclusion highlighting the interplay of technological progress, supply resilience, and service integration as foundations for sustained AI practice improvement

The conclusion synthesizes core themes: technological refinement, supply chain resilience, and tailored service models are converging to create a more outcome-driven veterinary AI environment. As techniques mature and digital integration spreads, stakeholders who align product capability with practical training and reliable consumable access will capture disproportionate value. Tariff-related disruptions in 2025 have underscored the need for flexible sourcing and nearshoring options, while regional heterogeneity highlights the importance of locally adapted go-to-market and support strategies.

Looking ahead, organizations that invest in rigorous training, interoperable equipment, and partnerships that bridge genetic supply with service delivery will be better positioned to translate scientific advances into operational improvements and client value. The discipline is primed for incremental but meaningful gains in reproductive efficiency and animal welfare, provided that industry actors remain focused on practical implementation challenges and build resilient commercial and logistical foundations to support sustained adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Artificial Insemination Market, by Animal Type

  • 8.1. Bovine
  • 8.2. Equine
  • 8.3. Ovine & Caprine
  • 8.4. Swine

9. Veterinary Artificial Insemination Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Extenders
    • 9.1.2. Pipettes
    • 9.1.3. Straws
  • 9.2. Equipment
    • 9.2.1. Ai Guns
    • 9.2.2. Cryogenic Storage Tanks
    • 9.2.3. Thawing Devices
  • 9.3. Seminal Materials
    • 9.3.1. Chilled
    • 9.3.2. Fresh
    • 9.3.3. Frozen

10. Veterinary Artificial Insemination Market, by End User

  • 10.1. Ai Centers
  • 10.2. Farms
  • 10.3. Veterinary Clinics

11. Veterinary Artificial Insemination Market, by Technology Type

  • 11.1. Conventional Ai
  • 11.2. Deep Intracervical Techniques
  • 11.3. Sexed Semen Ai

12. Veterinary Artificial Insemination Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Veterinary Artificial Insemination Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Artificial Insemination Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Veterinary Artificial Insemination Market

16. China Veterinary Artificial Insemination Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ABS Global, Inc.
  • 17.6. Alta Genetics
  • 17.7. Bovine Elite LLC
  • 17.8. Boviteq Inc.
  • 17.9. CRV B.V.
  • 17.10. Genus ABS
  • 17.11. Genus plc
  • 17.12. IMV Technologies SAS
  • 17.13. Inguran GmbH
  • 17.14. Merck & Co., Inc.
  • 17.15. Minitube International GmbH
  • 17.16. Neogen Corporation
  • 17.17. Select Sires Inc.
  • 17.18. Semex Alliance Inc.
  • 17.19. STgenetics
  • 17.20. Topigs Norsvin N.V.
  • 17.21. TransOva Genetics
  • 17.22. Valley Vet Supply
  • 17.23. Vytelle, Inc.
  • 17.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY OVINE & CAPRINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY OVINE & CAPRINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY OVINE & CAPRINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EXTENDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EXTENDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EXTENDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PIPETTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PIPETTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PIPETTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY STRAWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY STRAWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY STRAWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY AI GUNS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY AI GUNS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY AI GUNS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CRYOGENIC STORAGE TANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CRYOGENIC STORAGE TANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CRYOGENIC STORAGE TANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY THAWING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY THAWING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY THAWING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CHILLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CHILLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CHILLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FRESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FRESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FRESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY AI CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY AI CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY AI CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONVENTIONAL AI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONVENTIONAL AI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONVENTIONAL AI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY DEEP INTRACERVICAL TECHNIQUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY DEEP INTRACERVICAL TECHNIQUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY DEEP INTRACERVICAL TECHNIQUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEXED SEMEN AI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEXED SEMEN AI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEXED SEMEN AI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 153. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 154. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 178. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 179. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 185. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 186. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 187. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY SEMINAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA VETERINARY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)